The UK Bioscience Forum will return in person on 14 October 2021
A New Era of Biotechnology
We are delighted to launch the UK Bioscience Forum, which returns to being held in person in London this October!
The last 18 months have seen significant changes in the life sciences sector. While the COVID crisis has led to global challenges and immense suffering, it has also borne technological and scientific acceleration and development, a new global and national focus on drug discovery and healthcare as a priority, and new opportunities for companies in the life sciences sector – as outlined in the government’s Life Sciences Vision.
At the Bioscience Forum, we will discuss some of the most impactful changes that have occurred and consider how we can capture the speed of progress and the national focus on the sector, whether that be changes to financial support and incentives, using data technologies to further support scientific progress, political initiatives to boost UK capability, or exciting companies being launched in new areas.
You will hear from some of the industry's most inspiring figures and gain useful insights to help take your organisation forwards in a new era of biotechnology.
In addition to the keynote sessions, there will be a number of workshops and networking opportunities - both in person and online – as we look to maximise the enjoyment of a live event with some of the good bits that our online platform has to offer.
Conference: 8.30 - 5pm
Networking drinks: 5pm onwards
Jonathan Milner, Founder of Abcam plc, is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 60 companies and has assisted three technology companies to IPO on the London AIM Stock exchange.
Jonathan gained his doctorate in Molecular Genetics at Leicester University after graduating in Applied Biology at Bath. From 1992–95, he was a post-doctoral researcher at Bath, following which he worked at the University of Cambridge in the lab of Professor Tony Kouzarides studying cancer. He identified the market opportunity for supplying high-quality antibodies to support protein interaction studies, and in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides.
Jonathan is Chairman of Axol Bioscience Ltd and Camallergy Ltd and non-executive director of PhoreMost Ltd, Syndicate Room Ltd, Start Codon Ltd and HealX Ltd
Indro Mukerjee is an experienced CEO with board-level leadership experience in publicly listed, corporate multinational, new venture and private equity backed fast-moving technology and industrial companies.
Previously CEO of Watchstone Group plc – Brought in by institutions to stabilise and reshape a high-profile company operating in insurance, telematics and healthcare software and services.
At Plastic Logic, he restructured major venture capital-backed disruptive electronics company and created the FlexEnable Ltd. spin out.
At C-MAC MicroTechnology he built and sold three successful high technology companies operating in aerospace/defence, automotive and communications markets.
Indro’s main corporate leadership experience was based in the Netherlands with Philips (now NXP) Semiconductors BV, where he held several global board positions.
His earlier career included being Commercial Director within the leadership team which took VideoLogic (now Imagination Technologies) through an IPO, as well as senior management positions within Hitachi’s European semiconductor division.
Indro has a strong personal interest in the development of skills for industry and getting the best talent pipeline developed. He co-founded the UK Electronics Skills Foundation, which has developed into an innovative and successful partnership between industry and academia encouraging bright, young students to develop careers in the UK electronic systems industry.
Supporters and exhibitors